Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Rovere-Querini

Showing results (241-250 of 282) with videos related to

Pageof 29
Sort By:
Plos One|October 14, 2020
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort studyRebecca De Lorenzo, Caterina Conte, Chiara Lanzani, et al.
Andrology|November 2, 2022
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patientsGiada Amodio, Paolo Capogrosso, Marina Pontillo, et al.
Andrology|October 17, 2022
Testosterone in males with COVID-19: a 12-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
Haematologica|May 23, 2024
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort controlAnnalisa Ruggeri, Francesco Corrado, Antonio Voza, et al.
Emergency Medicine Journal : EMJ|December 15, 2022
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in MilanSarah Damanti, Enrica Bozzolo, Stefano Franchini, et al.
Science Translational Medicine|June 3, 2021
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophyGiorgia Careccia, Marielle Saclier, Mario Tirone, et al.
The Lancet. Rheumatology|August 25, 2020
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort studyGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
The Lancet. Rheumatology|June 6, 2020
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort studyGiulio Cavalli, Giacomo De Luca, Corrado Campochiaro, et al.
Panminerva Medica|February 4, 2022
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumoniaStefano Franchini, Francesca Mette, Giovanni Landoni, et al.
Le Infezioni in Medicina|December 12, 2025
Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptomsMarco Floridia, Liliana Elena Weimer, Aldo Lo Forte, et al.
Pageof 29

Showing results (241-250 of 282) with videos related to

Sort By:
Pageof 29
Plos One|October 14, 2020
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort studyRebecca De Lorenzo, Caterina Conte, Chiara Lanzani, et al.
Andrology|November 2, 2022
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patientsGiada Amodio, Paolo Capogrosso, Marina Pontillo, et al.
Andrology|October 17, 2022
Testosterone in males with COVID-19: a 12-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
Haematologica|May 23, 2024
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort controlAnnalisa Ruggeri, Francesco Corrado, Antonio Voza, et al.
Emergency Medicine Journal : EMJ|December 15, 2022
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in MilanSarah Damanti, Enrica Bozzolo, Stefano Franchini, et al.
Science Translational Medicine|June 3, 2021
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophyGiorgia Careccia, Marielle Saclier, Mario Tirone, et al.
The Lancet. Rheumatology|August 25, 2020
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort studyGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
The Lancet. Rheumatology|June 6, 2020
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort studyGiulio Cavalli, Giacomo De Luca, Corrado Campochiaro, et al.
Panminerva Medica|February 4, 2022
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumoniaStefano Franchini, Francesca Mette, Giovanni Landoni, et al.
Le Infezioni in Medicina|December 12, 2025
Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptomsMarco Floridia, Liliana Elena Weimer, Aldo Lo Forte, et al.
Pageof 29